To elucidate the functional link between WDR5 expression and response to chemotherapy, we next analyzed datasets of a recently published human colon cancer-patient clinical trial for combined PD-1, BRAF, and MEK inhibition [41]. The gene discussed is MAP2K7; the disease is malignant colon neoplasm.